Literature DB >> 15867363

RASSF1A suppresses the c-Jun-NH2-kinase pathway and inhibits cell cycle progression.

Young Mi Whang1, Yeul Hong Kim, Jun Suk Kim, Young Do Yoo.   

Abstract

Some oncogenes, such as activated Ras, cause the malignant transformation of lung cells. c-Jun-NH2-kinase (JNK) activation is essential for the oncogenic function of these cells. In this study, we show that RASSF1A inhibits the growth of lung cancer cells by blocking the JNK pathway. The exogenous expression of RASSF1A suppressed JNK phosphorylation, and cells stably transfected with RASSF1A showed reduced JNK and c-Jun phosphorylation and Cyclin D1 down-regulation. An in vitro kinase assay showed that the exogenous expression of RASSF1A inhibited JNK activity and that JNK activity suppression due to ectopically expressed RASSF1A was revived by RASSF1A siRNA treatment. Based on our data, we suggest that RASSF1A exerts a tumor-suppressing effect by blocking oncogene-mediated JNK activation in lung cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15867363     DOI: 10.1158/0008-5472.CAN-04-2792

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  27 in total

1.  Regulation of demethylation and re-expression of RASSF1A gene in gastric cancer cell lines by combined treatment of 5-Aza-CdR and NaB.

Authors:  Wen-Jing Shen; Dong-Qiu Dai; Yue Teng; Hong-Bo Liu
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

2.  Relationship between the expression of RASSF1A protein and promoter hypermethylation of RASSF1A gene in bladder tumor.

Authors:  Jianting Hu; Hongzhao Li; Taoping Shi; Xin Ma; Baojun Wang; Hua Xu; Xiang Ai; Zhenghua Ju; Chao Wang; Guoxi Zhang; Xu Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-05-15

3.  Release of RASSF1C from the nucleus by Daxx degradation links DNA damage and SAPK/JNK activation.

Authors:  Daiju Kitagawa; Hiroaki Kajiho; Takahiro Negishi; Seiji Ura; Tomomi Watanabe; Teiji Wada; Hidenori Ichijo; Toshiaki Katada; Hiroshi Nishina
Journal:  EMBO J       Date:  2006-06-29       Impact factor: 11.598

4.  RASSF1A suppresses melanoma development by modulating apoptosis and cell-cycle progression.

Authors:  Mei Yi; Jianbo Yang; Xiang Chen; Ji Li; Xiayu Li; Li Wang; Yixin Tan; Wei Xiong; Ming Zhou; James B McCarthy; Guiyuan Li; Bo Xiang; Hongfu Xie
Journal:  J Cell Physiol       Date:  2011-09       Impact factor: 6.384

5.  Menin determines K-RAS proliferative outputs in endocrine cells.

Authors:  Chester E Chamberlain; David W Scheel; Kathleen McGlynn; Hail Kim; Takeshi Miyatsuka; Juehu Wang; Vinh Nguyen; Shuhong Zhao; Anastasia Mavropoulos; Aswin G Abraham; Eric O'Neill; Gregory M Ku; Melanie H Cobb; Gail R Martin; Michael S German
Journal:  J Clin Invest       Date:  2014-08-18       Impact factor: 14.808

6.  Methylation of RASSF1A gene promoter is regulated by p53 and DAXX.

Authors:  Hailong Zhang; Jing He; Jiansha Li; Dan Tian; Lubing Gu; Muxiang Zhou
Journal:  FASEB J       Date:  2012-10-04       Impact factor: 5.191

7.  Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients.

Authors:  Yu-Cai Wang; Zheng-Hong Yu; Chang Liu; Li-Zhi Xu; Wen Yu; Jia Lu; Ren-Min Zhu; Guo-Li Li; Xin-Yi Xia; Xiao-Wei Wei; Hong-Zan Ji; Heng Lu; Yong Gao; Wei-Min Gao; Long-Bang Chen
Journal:  World J Gastroenterol       Date:  2008-05-21       Impact factor: 5.742

8.  RASSF6 promotes p21(Cip1/Waf1)-dependent cell cycle arrest and apoptosis through activation of the JNK/SAPK pathway in clear cell renal cell carcinoma.

Authors:  Ying-Ying Liang; Li-Sheng Zheng; Yuan-Zhong Wu; Li-Xia Peng; Yun Cao; Xue Cao; Ping Xie; Bi-Jun Huang; Chao-Nan Qian
Journal:  Cell Cycle       Date:  2014-03-10       Impact factor: 4.534

9.  Activator protein-1 involved in growth inhibition by RASSF1A gene in the human gastric carcinoma cell line SGC7901.

Authors:  Zheng-Hao Deng; Ji-Fang Wen; Jing-He Li; De-Sheng Xiao; Jian-Hua Zhou
Journal:  World J Gastroenterol       Date:  2008-03-07       Impact factor: 5.742

10.  Intravesical delivery of rapamycin via folate-modified liposomes dispersed in thermo-reversible hydrogel.

Authors:  Ho Yub Yoon; In Ho Chang; Yoon Tae Goo; Chang Hyun Kim; Tae Hoon Kang; Soo-Yeon Kim; Sang Jin Lee; Seh Hyon Song; Young Mi Whang; Young Wook Choi
Journal:  Int J Nanomedicine       Date:  2019-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.